SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001399529-21-000015
Filing Date
2021-01-12
Accepted
2021-01-12 21:38:45
Documents
1
Period of Report
2021-01-08

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_161050550997127.html 4  
1 FORM 4 wf-form4_161050550997127.xml 4 12121
  Complete submission text file 0001399529-21-000015.txt   13483
Mailing Address C/O DICERNA PHARMACEUTICALS, INC. 87 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140
Business Address
FAMBROUGH DOUGLAS (Reporting) CIK: 0001259856 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36281 | Film No.: 21524938

Mailing Address 75 HAYDEN AVENUE LEXINGTON MA 02421
Business Address 75 HAYDEN AVENUE LEXINGTON MA 02421 617 621 8097
Dicerna Pharmaceuticals Inc (Issuer) CIK: 0001399529 (see all company filings)

IRS No.: 205993609 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations